Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 AUD | +1.36% |
|
-0.33% | -32.05% |
01/05 | Nanosonics Submits De Novo Application to US FDA for CORIS Cleaning Technology | MT |
15/03 | Nanosonics Chief Technology Officer to Retire | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 105.73 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 4.69 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-32.05% | 60Cr | B+ | ||
+4.18% | 21TCr | B | ||
+8.00% | 19TCr | B- | ||
+31.86% | 16TCr | B- | ||
+33.21% | 11TCr | A- | ||
+2.28% | 6.43TCr | A- | ||
+21.14% | 5.57TCr | B+ | ||
+0.11% | 4.84TCr | B+ | ||
-6.76% | 3.78TCr | A | ||
+0.78% | 3.56TCr | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NAN Stock
- Ratings Nanosonics Limited